Literature DB >> 26110780

Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum.

Jaime Prat1.   

Abstract

Ovarian, fallopian tube, and peritoneal cancers have a similar clinical presentation and are treated similarly, and current evidence supports staging all 3 cancers in a single system. The primary site (i.e. ovary, fallopian tube, or peritoneum) should be designated where possible. The histologic type should be recorded. Intraoperative rupture ("surgical spill") is IC1; capsule ruptured before surgery or tumor on ovarian or fallopian tube surface is IC2; and positive peritoneal cytology with or without rupture is IC3. The new staging includes a revision of stage III patients; assignment to stage IIIA1 is based on spread to the retroperitoneal lymph nodes without intraperitoneal dissemination. Extension of tumor from omentum to spleen or liver (stage IIIC) should be differentiated from isolated parenchymal metastases (stage IVB).
© 2015 American Cancer Society.

Entities:  

Keywords:  Fallopian tube cancer; ovarian cancer; peritoneal cancer; staging

Mesh:

Year:  2015        PMID: 26110780     DOI: 10.1002/cncr.29524

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  Clinical Characteristics and Survival of Patients with Malignant Ovarian Tumors in Addis Ababa, Ethiopia.

Authors:  Swantje Piszczan; Dawit Desalegn; Hezkiel Petros; Mengistu Gurmu; Eric Sven Kroeber; Adamu Addissie; Rafael Mikolajczyk; Rahel G Ghebre; Assefa Mathewos; Christoph Thomssen; Ahmedin Jemal; Eva Johanna Kantelhardt
Journal:  Oncologist       Date:  2019-04-25

2.  Expression of CCL18 gene in ovarian cancer and its impact on the biologic function of ovarian cancer cells.

Authors:  Ying-Zhu Yang; Wei Zhang; Bing-Bing Zhao; Li Li
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

3.  Survival Outcomes With Reduced Doses of Adjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer.

Authors:  Juhun Lee; Jong Mi Kim; Yoon Hee Lee; Gun Oh Chong; Dae Gy Hong
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

4.  EANM guideline on the role of 2-[18F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA).

Authors:  Roberto C Delgado Bolton; Nicolas Aide; Patrick M Colletti; Annamaria Ferrero; Diana Paez; Andrea Skanjeti; Francesco Giammarile
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-07-03       Impact factor: 9.236

5.  ST3Gal3 confers paclitaxel‑mediated chemoresistance in ovarian cancer cells by attenuating caspase‑8/3 signaling.

Authors:  Xian Zhang; Xinying Yang; Ming Chen; Shaolie Zheng; Jinyuan Li; Shaoqiang Lin; Xiaoyu Wang
Journal:  Mol Med Rep       Date:  2019-09-26       Impact factor: 2.952

6.  Death of 43 Indonesian women with ovarian cancer: A case series.

Authors:  Pungky Mulawardhana; Poedjo Hartono; Hari Nugroho; Atika Ayuningtyas
Journal:  Int J Surg Case Rep       Date:  2020-12-24

7.  Staging classification for cancer of the ovary and the fallopian tube should include in situ carcinoma.

Authors:  Wiebren A A Tjalma
Journal:  J Gynecol Oncol       Date:  2015-09-23       Impact factor: 4.401

8.  Giant mucinous ovarian borderline tumor. A good lesson from an asymptomatic case.

Authors:  Vincenzo Pilone; Salvatore Tramontano; Pierpaolo Picarelli; Angela Monda; Mafalda Romano; Michele Renzulli; Carmen Cutolo
Journal:  Int J Surg Case Rep       Date:  2018-07-26

9.  Free CA125 promotes ovarian cancer cell migration and tumor metastasis by binding Mesothelin to reduce DKK1 expression and activate the SGK3/FOXO3 pathway.

Authors:  Qianyu Huo; Chen Xu; Yanhong Shao; Qin Yu; Lunhui Huang; Yunde Liu; Huijing Bao
Journal:  Int J Biol Sci       Date:  2021-01-14       Impact factor: 6.580

10.  High FOXA1 immunohistochemical expression level associates with mucinous histology, favorable clinico-pathological prognostic parameters and survival advantage in epithelial ovarian cancer.

Authors:  Heba Sheta; Amal Abd El Hafez; Maha Saif; Alyaa R Elsergany; Doaa Al Emam; Mahmoud Mohamed Abdelrazik
Journal:  Pathologica       Date:  2021-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.